NIH-funded research R15 grant

Understanding how certain bacteria manage their genetic material during reproduction

Official title: Development-Associated Linear Chromosome Segregation in Streptomyces

Funded at Duquesne University · NIH-10579038 · Data updated 2026-11-12

This study is looking at a type of bacteria called Streptomyces, which helps make important medicines like antibiotics, to learn how they manage their genetic material when they create spores, and this could help us find better ways to use these bacteria in medicine.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionDuquesne University
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startSeptember 20, 2022
Project endAugust 31, 2025
Funding year2022
Award (this year)$401,069
NIH project number1R15GM148966-01
Project IDNIH-10579038 on NIH RePORTER

Who could benefit from this research

Could help

Patients who may benefit from this research include those with bacterial infections that are resistant to current treatments.

Less likely to help

Patients with non-bacterial infections or those not affected by antibiotic-resistant bacteria may not receive benefits from this research.

What this research studies

This research focuses on Streptomyces, a type of bacteria known for producing important medicines like antibiotics. The study aims to explore how these bacteria organize and segregate their genetic material during their unique life cycle, particularly during spore formation. By using genetic techniques, researchers will investigate a specific protein that may play a crucial role in this process. This understanding could lead to advancements in how we utilize these bacteria for medical purposes.

Why it matters

Potential benefit: If successful, this research could enhance the development of new antibiotics and other therapeutic agents derived from Streptomyces.

How similar studies have gone: Other research has shown success in understanding bacterial genetics and its implications for antibiotic production, making this approach promising.

Where this research is happening

  • Duquesne University
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Mc Cormick, Joseph R — Duquesne University
  • Study coordinator: Mc Cormick, Joseph R

Related research

Other NIH-funded projects on the same topics.

  • Genes essential for egg function and fertilization

    Researchers are studying how eggs become ready to fertilize and trigger embryo development, using a worm model to uncover key egg-side Molecules that could inform fertility and birth control research for adults.

    NIH research Duquesne University · Pittsburgh, United States · NIH-11619389

  • Systemic travel of damaged DNA in autoimmune skin disorders

    A research project looks at tiny particles shed from UV-damaged skin that carry damaged DNA and travel through the body, potentially worsening autoimmune inflammation in people with photosensitive conditions like lupus.

    NIH research Duquesne University · Pittsburgh, United States · NIH-11537827

  • Injectable 3D Tissues to Support Regulatory T Cells for Better Allograft Tolerance

    This grant explores a new injectable 3D cell therapy approach to help regulate the immune system and reduce transplant rejection in people who receive organ transplants.

    NIH research Duquesne University · Pittsburgh, United States · NIH-11350997

  • Mosquito bacteria designed to block malaria spread

    Researchers are modifying harmless bacteria inside mosquitoes so the bugs can't pass malaria to people.

    NIH research Duquesne University · Pittsburgh, United States · NIH-11323096

  • How human cell proteins help herpes simplex virus copy and repair its DNA

    The team is identifying how human cell proteins interact with herpes simplex virus DNA during copying, repair, and gene activation to guide future treatments for people with HSV infections.

    NIH research Duquesne University · Pittsburgh, United States · NIH-11261202

  • Restoring the brain's cleanup cells to help in Lewy body disease

    This project looks at whether removing and then regrowing the brain's immune cells can help clear harmful protein clumps that damage people with Lewy body disease.

    NIH research Duquesne University · Pittsburgh, United States · NIH-11194408

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.